Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular Lenses

This study has been completed.
Information provided by:
Innovative Medical Identifier:
First received: October 28, 2009
Last updated: June 24, 2011
Last verified: June 2011
This study will determine the ability of three different intraocular lenses to accommodate in patients who have previously undergone bilateral intraocular lens implantation.


Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional

Further study details as provided by Innovative Medical:

Primary Outcome Measures:
  • Amplitude of accommodation on COAS and how it correlates with: spherical aberration on the COAS, pupil size at near as measured with COAS, spherical aberration on the topography, patient reported nead for spectacles for reading [ Time Frame: one study visit ]

Secondary Outcome Measures:
  • Amplitude of accommodation on pushdown test - and how it compares to the COAS test results [ Time Frame: one study visit ]

Estimated Enrollment: 30
Study Start Date: October 2009
Study Completion Date: June 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Bilateral intraocular lens implantation.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Primary care clinic

Inclusion Criteria:

  • Patients age 18 and older
  • Patients must have undergone cataract surgery and have bilateral implants of the same model. The models eligible for inclusion include:

    • Crystalens
    • Crysalens HD
    • Tecnis One monofocal
  • Patients must have a healthy cornea and macula
  • Patients must have 20/25 or better best corrected vision
  • Able to provide written informed consent

Exclusion Criteria:

  • BCVA of less than 20/25
  • On oral medications that could potentially block accommodation:

    • First generation antihistamines
    • Anticholinergic agents
    • Anti-psychotic medications
    • Antidepressant medications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01004549

United States, Florida
The Center for Excellence in Eye Care
Miami, Florida, United States
Sponsors and Collaborators
Innovative Medical
Principal Investigator: William Trattler, MD The Center for Excellence in Eye Care
  More Information

Responsible Party: William Trattler MD, The Center for Excellence in Eye Care Identifier: NCT01004549     History of Changes
Other Study ID Numbers: Accomodation study
Study First Received: October 28, 2009
Last Updated: June 24, 2011

Keywords provided by Innovative Medical:
Patients who have previously undergone bilateral intraocular lens implantation

Additional relevant MeSH terms:
Signs and Symptoms processed this record on May 22, 2017